OneSource Specialty Pharma Limited (BOM:544292)
1,671.65
+56.55 (3.50%)
At close: Jul 13, 2026
BOM:544292 Revenue
In the fiscal year ending March 31, 2026, OneSource Specialty Pharma had annual revenue of 14.22B INR, down -1.61%. OneSource Specialty Pharma had revenue of 4.28B in the quarter ending March 31, 2026, with 0.53% growth.
Revenue
14.22B
Revenue Growth
-1.61%
P/S Ratio
13.12
Revenue / Employee
10.07M
Employees
1,412
Market Cap
186.52B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 14.22B | -232.63M | -1.61% |
| Mar 31, 2025 | 14.45B | 12.73B | 740.43% |
| Mar 31, 2024 | 1.72B | 1.33B | 344.07% |
| Mar 31, 2023 | 387.14M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionOneSource Specialty Pharma News
- 2 months ago - OneSource Specialty Pharma Slides: Q4 2026 - Filings
- 2 months ago - OneSource Specialty Pharma Quarterly report: Q4 2026 - Filings
- 6 months ago - OneSource Specialty Pharma Slides: Q3 2026 - Filings
- 6 months ago - OneSource Specialty Pharma Quarterly report: Q3 2026 - Filings
- 8 months ago - OneSource Specialty Pharma Slides: Q2 2026 - Filings
- 8 months ago - OneSource Specialty Pharma Quarterly report: Q2 2026 - Filings
- 1 year ago - OneSource Specialty Pharma Quarterly report: Q1 2026 - Filings
- 1 year ago - OneSource Specialty Pharma Slides: Q1 2026 - Filings